Pharma Journalist -

PharmaMar announced the start of a multicenter quadruple combination clinical study with Aplidin (plitidepsina), along with other compounds for the treatment of multiple myeloma.…
Read More...

Soin Neuroscience, a biotech startup based in Dayton, OH, has recently signed a drug development deal with Cleveland Diabetes Care for SNI's lead developmental pain drug TV1001SR- which…
Read More...

Avara Pharmaceutical Services has signed an agreement with Pfizer Inc. to acquire the Liscate, Italy sterile manufacturing facility. "This acquisition is an important component of our…
Read More...

HitGen Ltd announced that the company has entered into a multi-target multi-year collaboration with LEO Pharma A/S , to discover novel small molecule leads for multiple therapeutic…
Read More...

Charles River Laboratories International, Inc. announced that it has acquired Brains On-Line, a leading contract research organization (CRO) providing critical data that advances novel…
Read More...

Nexus Pharmaceuticals announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Isoproterenol…
Read More...

Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the…
Read More...

Takeda Pharmaceutical Company Limited and Molecular Templates, Inc. today announced a collaboration agreement for oncology drug discovery programs. The collaboration will apply…
Read More...

Omeros Corporation announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of Immunoglobulin A (IgA) nephropathy.…
Read More...

Achieve Life Sciences, Inc. announced the closing of its previously announced merger with OncoGenex Pharmaceuticals, as a result of which the stockholders of Achieve have become the…
Read More...